Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of selected culture conditions on production of Shiga-like toxin-II variant by an edema disease strain of Escherichia coli (412) and E. coli
TB1
(pCG6) containing the cloned genes for Shiga-like toxin-II variant were examined. Incubation time, culture media, incubation temperature, starting pH of the culture medium, aeration, static culture, anaerobiosis, carbon sources, amino acids, antibiotics, and mitomycin C were investigated. The study showed that Shiga-like toxin-II variant was primarily cell associated and that strain
TB1
(pCG6) produced as much as 100 times more toxin than did strain 412. Culture conditions that resulted in the greatest yield of Shiga-like toxin-II variant were incubation at 37 degrees C for 24 h with
shaking
in syncase broth initially adjusted to pH 8.5. Aerobic culture with
shaking
resulted in higher yields of Shiga-like toxin-II variant than did static aerobic or anaerobic culture. Addition of various carbon sources or amino acids, or tetracycline, lincomycin, or trimethoprim:sulfadoxine did not increase yields of toxin. The amount of Shiga-like toxin-II variant in supernatant preparations from strain
TB1
(pCG6) was significantly increased by addition of mitomycin C to the culture medium.
...
PMID:Effects of culture conditions on yield of Shiga-like toxin-IIv from Escherichia coli. 250 70